Therefore, a positive regulator of Parkin, such as SUMO-1, may simply disintegrate the self-inhibiting conformation of Parkin protein or enhance the binding of E2 to the substrate without causing degradation of the Parkin protein [49], thereby causing apoptosis of cancer cells. This evidence concerns the gene SUMO1 and cancer.